Ice man

Quick links to important sections

Ice man

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ice man

Quick Facts

Property Description
Active Ingredient Levomenthol (L-Menthol)
Form Nasal spray, solution, topical preparation
Pharmacological Class Counterirritant, Topical Analgesic
Common Use Symptomatic relief of nasal congestion and localized discomfort
Origin Nature-identical (derived from peppermint)

What Type of Medicine is Ice man and What is its Composition?

The preparation referred to as Ice man is a pharmaceutical entity defined by its single primary active ingredient, Levomenthol (or L-Menthol), which acts as a topical analgesic and counterirritant. This key substance is chemically classified as a monoterpenoid cyclic alcohol, functioning locally to relieve minor discomfort and congestion. Levomenthol is the specific levorotatory isomer of menthol, distinguishing it within its chemical family, a distinction that is clinically recognized for its potent sensory effect. The pharmacological class of counterirritants focuses on providing relief through a localized sensory effect rather than systemic action, a characteristic typical of these over-the-counter preparations.

Levomenthol Origin and Available Forms

Levomenthol is a nature-identical compound, meaning it is chemically synthesized to be structurally and functionally equivalent to the menthol found naturally in the essential oils of the peppermint plant (Mentha piperita). This ensures a high standard of purity for pharmaceutical use. The preparation is made available in various localized dosage forms, including a nasal spray, a topical solution, or as an ingredient within other topical preparations. These forms are designed for two primary routes of administration: directly topical application onto the skin or mucous membranes, and inhalational delivery via the nasal passages. The application of menthol-containing products to the skin or nasal mucosa is the primary method for delivering these effects.

Core Purpose and Mechanism of Symptomatic Relief

The core purpose of this preparation is to offer immediate, symptomatic relief from sensations of minor localized discomfort and feelings of restricted breathing associated with nasal congestion. This effect is achieved because Levomenthol activates the TRPM8 receptor on sensory nerves, creating a powerful cooling sensation that serves as a counter-signal. Inhalations of menthol are utilized for the temporary relief of blocked nasal passages. The cooling sensation functions as a counter-irritation effect, temporarily altering the body's perception of the underlying discomfort, such as during a typical common cold where the goal is to experience the sensation of clearer airways.

What side effects are possible with Ice man?

Possible Side Effects and Safety Information


The drug Ice man is associated with a range of possible side effects that require careful consideration. As a potent central nervous system stimulant, its primary risks relate to cardiovascular and neuropsychiatric function.

Common and Mild Side Effects

Many users may experience mild, transient side effects. These can include insomnia (trouble sleeping), dry mouth, headache, loss of appetite, and noticeable physical signs such as dilated pupils and excessive sweating. Gastrointestinal effects like nausea or stomach upset may also occur.

Serious Adverse Effects

More serious side effects primarily involve the cardiovascular and central nervous systems. These effects necessitate immediate medical attention and may include:

  • Cardiovascular Issues: Significant increases in heart rate and blood pressure, irregular heartbeat (arrhythmias), chest pain, and in severe cases, stroke or heart attack. Long-term use is associated with an increased risk of chronic heart and kidney problems.
  • Psychological and Neurological Issues: Severe anxiety, paranoia, and psychosis (characterized by hallucinations and delusions). Users may also experience severe mood disturbances, confusion, and aggressive or unpredictable behavior.

Safety Considerations

Dependency and Addiction are significant risks with Ice man, which can lead to a compulsive need to use the substance and difficult withdrawal symptoms upon cessation. Furthermore, use of Ice man can lead to complications such as severe weight loss and significant dental issues (often referred to as “meth mouth”).

The drug may also cause or worsen conditions related to blood flow, such as Raynaud's phenomenon, leading to numbness, pain, or color changes in the extremities, especially when exposed to cold. Individuals with pre-existing heart conditions, high blood pressure, or a history of mental health disorders are at a significantly higher risk for serious complications and should avoid use.

Overdose and Emergency Response

Overdose and when to seek help

Overdose Scope

The regulatory profile for Levomenthol overdose focuses on risks associated with ingestion or accidental systemic exposure, differing from the intended topical use. Documented manifestations may include central nervous system effects such as drowsiness, lethargy, ataxia, nystagmus, and hyperactivity, alongside gastrointestinal symptoms like nausea and vomiting. A serious potential outcome documented in the regulatory information is primary respiratory depression.

The requirement for prompt medical attention is specifically emphasized as being critical for adults as well as for children following accidental ingestion, even if no initial symptoms are present.

Emergency Action and Management

Official guidance mandates that if accidental overdose occurs or the product is swallowed, one must get medical help or contact a Poison Control Center right away. This regulatory instruction constitutes the required threshold for urgent help-seeking based on official documents. The management of toxicity is defined as symptomatic and supportive treatment. Procedural options mentioned in regulatory protocols include gastric lavage; however, no specific antidote is listed in the official labeling. Specific continuous monitoring requirements beyond seeking immediate medical attention are not explicitly detailed.

Connection to the Overall Overdose Profile

Regulatory documents strictly define the overdose profile by listing specific neurotoxic manifestations and identifying primary respiratory depression as a severe outcome. This risk necessitates a mandatory, immediate call to emergency services or a poison control center, establishing the official threshold for when urgent medical help must be sought. The subsequent clinical approach is defined as being supportive, with no specific antidote documented.

Therapeutic Uses of Ice man

What Ice man Treats: Main Uses and Benefits

The preparation is used in situations involving certain distressing symptoms, generally offering supportive management for temporary physical discomfort across two primary domains. The substance is generally used as a topical counterirritant and for relief during cold symptoms, consistent with its long-standing use in over-the-counter products.

Symptomatic Management and Core Benefits

Ice man is relevant in contexts marked by increased discomfort, commonly used across conditions presenting with acute episodes characterized by nasal and upper respiratory congestion and minor localized discomfort. Its core benefit generally assists with easing the perception of stuffiness and temporary aches. The primary purpose is to offer supportive relief from sensations that interfere with daily comfort. This preparation is applied in scenarios where additional management of discomfort is required, such as managing the temporary, bothersome feeling of a blocked nose, superficial muscle soreness, or minor skin irritation. It provides support that generally helps ease the overall symptom burden during symptomatic periods and may assist with maintaining functional stability.


Quick Fact: Relief for Congestion & Discomfort
Primary Indication Areas Nasal stuffiness (symptomatic) and minor localized muscular aches
Core Benefit Contributes to improved comfort and supports relief of bothersome sensory symptoms
Typical Contexts Acute episodes of common cold; temporary physical strain or irritation

Regulatory References

  1. authoritative government records

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ice man — official regulatory information

Regulatory documents define eligibility for Levomenthol-based preparations ("Ice man") based on age, hypersensitivity, and pre-existing health status.


Eligibility Scope

Classification Eligibility Rule (Based on Official Labeling)
Populations Allowed Adults and the elderly are generally permitted for labeled use. Adolescents (aged 12 and over) are typically allowed at the standard adult dosage.
Populations Contraindicated Must not be used by patients with known hypersensitivity to Levomenthol or other product components. Contraindicated in children below specific, labeled age cut-offs, often under 12 years for combination products. Use is also restricted on broken or denuded skin for topical forms.
Conditional or Restricted Use Use is generally not recommended in pregnant or breastfeeding women without medical consultation due to insufficient data. Caution is required for patients with severe hepatic or renal impairment or those with certain pre-existing conditions like asthma or cardiovascular disease (for some formulations).

Age-Related Eligibility Rules

Pediatric use is generally contraindicated below specified thresholds, which may be as high as 12 years for some preparations. Safety and effectiveness in children, especially below the age of 2, are often cited in regulatory documents as not established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Ice man (Levomenthol), when utilized as a single-agent topical or inhalational product, defines a concise interaction profile centered on local administration restrictions.


Official Interaction Profile

Classification Restriction or Finding
Pharmacodynamic Interactions Co-administration with other topical or local preparations on the same site may lead to additive local effects, such as increased skin irritation or enhanced local absorption of the co-administered agent.
Contraindications No systemic medicinal products are formally designated as contraindicated for co-administration in the official regulatory labels.
Systemic PK Interactions Regulatory labels do not document systemic pharmacokinetic interactions, including those mediated by major drug-metabolizing enzymes (CYP450) or drug transporters.

Interaction-Related Constraints

The primary documented constraint requires avoiding the concurrent application of other menthol-containing products or other topical preparations to the exact same skin or mucous membrane application area. This spatial restriction is intended to prevent the pharmacodynamic reinforcement of the counterirritant action. The general absence of documented systemic drug-drug interactions indicates that the product is not officially noted by health authorities to significantly alter the exposure or clearance of other systemically administered medicines.

Mechanism of Action

Direct Activation of ∗TRPM8∗ Cold Receptors

The primary mechanism involves Levomenthol acting as a direct agonist of the Transient Receptor Potential Melastatin 8 ( TRPM8) ion channel, a receptor found on peripheral sensory nerve endings. This molecular interaction immediately triggers an ionic influx, rapidly initiating a nerve signal that the central nervous system interprets as intense cooling.


Counter-Irritation and Local Nerve Signal Modulation

The intense, artificially generated TRPM8 signal acts as a counter-stimulus, actively interfering with the transmission of pre-existing nociceptive signals. Additionally, Levomenthol contributes to a localized modulation of nerve conduction by transiently inhibiting Voltage-Gated Sodium Channels ( Na v) on the peripheral nerves, which reduces the overall transmission of peripheral sensory signals.


Altered Perception of Airflow

In the nasal passages, the rapid activation of TRPM8-expressing trigeminal sensory nerve endings alters the perception of patency. By stimulating the neural pathways responsible for sensing air temperature and flow, the molecule modulates the perceived resistance within the nasal cavity, contributing to an altered perception of nasal patency through a sensory effect rather than structural decongestion.

Dosage and Administration Information

How to Use Ice man

The administration of Ice man (Levomenthol) is defined by its classification as a topical and inhalational product, focusing on high-level procedural patterns rather than systemic dosing. The preparation is designated for use via the Inhalational route, typically delivered through a nasal inhaler, or by Topical/Cutaneous application using creams, ointments, or solutions. This dual-route specification is central to its use protocol.

Official Administration Guidelines

Feature Description
Route of Administration Inhalational or Topical/Cutaneous
Frequency Pattern As-needed (PRN) for symptomatic relief, up to a maximum frequency (e.g., not more than 4 times a day for certain topical products).
Age Restriction The nasal inhaler is not for use in children under 6 years of age. Specific pediatric application amounts are outlined for older children in some topical regimens.

Procedural and Contextual Constraints

The usage protocol is defined by short-term, symptomatic application. For the nasal inhaler, the typical action involves inserting the device into one nostril while closing the other, followed by a deep inhalation. Topical application requires users to apply a thin layer to the affected external area and avoid covering the treated area tightly or applying external heat, which is a procedural constraint to manage absorption. The preparation is mandated for external use only, with instructions directing users to avoid contact with eyes and broken skin.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Levomenthol (Ice man)

Evidence for Use in Managing Perceived Nasal Stuffiness

The research describes evidence that includes short-term Randomized Controlled Trials (RCTs) and systematic reviews focusing on Levomenthol's use for temporary feelings of restricted breathing, associated with acute episodes, such as the common cold. Research examined outcomes related to systemic or functional imbalance, specifically by monitoring patient-reported outcomes describing perceived discomfort and clearness of the nasal passage.

These studies conducted during periods of increased symptom activity generally describe patterns observed in the studies over the short term. Findings data show patterns related to a rapid, temporary patient-reported outcomes describing perceived discomfort and clearness following application. However, research examined objective physiological outcomes, such as physically measured nasal airway resistance, and these findings data show patterns related to limited or no corresponding change in the actual physical capacity of the nasal passage. This suggests the observed activity was associated with a sensory effect rather than a physiological change in nasal swelling.

Evidence for Use as a Topical Counterirritant for Minor Aches

Levomenthol was studied for topical preparations in trials examining outcomes related to physical discomfort, particularly symptomatic relief for minor localized discomfort and aches. The evidence was evaluated in RCTs that compared Levomenthol-containing creams or gels with a placebo (a non-active cream) in various adult populations. Research examined outcomes such as patient-reported pain intensity scores and laboratory measures of pain pressure threshold (PPT), which studies monitored tissue sensitivity.

Trials studies report how symptoms evolved in the observed populations where the application was associated with changes in acute pain perception and altered sensory thresholds shortly after use. However, evidence suggests that much of the available, controlled research involves Levomenthol in combination with other active analgesic ingredients.

Research Gaps and What Remains Uncertain

There is limited information for long-term outcomes when Levomenthol was studied for use in maintenance or chronic conditions. Data for certain groups remain insufficient, particularly concerning the use of Levomenthol in pediatric populations for both indications, and for older adults with specific comorbidities. The extent to which results apply only to the populations studied (primarily healthy adults or those with acute, mild symptoms) evidence is limited outside of these groups.

Frequently Asked Questions (FAQ)

Common questions about Ice man (FAQ)


Q: Is Ice man a common or prescription-only medicine?

The active ingredient in Ice man, Levomenthol, is commonly found in approved products that are designated as over-the-counter (OTC) preparations. This classification means the preparation is often accessible for purchase without a prescription for its labeled uses, though availability may vary.


Q: What happens if I miss taking a dose of Ice man?

Since Ice man is generally used as an 'as-needed' product for temporary symptoms, official guidance typically suggests that if an application is missed, it is appropriate to skip the missed application and continue with the next one when needed. This approach avoids the potential for excessive use.


Q: Can Ice man cause skin reactions or a rash?

Official product information indicates that common, localized side effects may include skin irritation, redness, or a burning sensation at the site of application. While less frequent, more serious reactions such as a generalized rash or swelling have been reported. If serious reactions such as a rash or swelling occur, regulatory information indicates this is a situation that requires seeking medical attention.


Q: Is it okay to drive or operate machinery while taking Ice man?

For products containing Levomenthol, especially combination products, official documents suggest individuals refrain from driving or operating machinery until they understand how the product affects them. This caution is advised because there is a potential for side effects, such as drowsiness, that could affect mental capacity.


Q: Where can I find the official regulatory information about Ice man?

Official patient and technical information about the active ingredient, Levomenthol, can be accessed through government-sponsored medical databases. Reliable resources include the NIH's PubChem database and the MedlinePlus service, which collect and share regulatory information globally.


Q: Is Ice man used globally, or only in certain countries?

Levomenthol is an active ingredient that is listed in the regulatory databases of many countries around the world. Consequently, the ingredient is used globally in a variety of branded and generic products for topical and inhalational use.


Q: Has Ice man been recalled or flagged for safety issues?

Information on product safety, recalls, or flagging for regulatory issues is typically communicated by health authorities such as the MHRA or EMA. For a combination product, safety updates have been issued regarding the concentration of ingredients or required labeling changes. Patients may check the regulatory status updates issued by their local health authority.


Q: Can Ice man be taken with alcohol?

Regulatory information for some products containing Levomenthol advises that users should avoid alcoholic beverages. The official caution is typically related to the potential for interactions with other ingredients that may be present in a combination product.


Q: Are the side effects of Ice man the same for everyone?

Official regulatory texts describe the list of possible adverse effects, but also acknowledge that a product's effects may need to be assessed on an individual basis. This acknowledgment suggests that the experience and severity of side effects may vary from person to person.


Q: Is Ice man a controlled substance?

In the United States, Levomenthol is not listed under the federal Controlled Substances Act (CSA) drug schedules. This means the ingredient is not subject to the same strict governmental controls as scheduled drugs.


Q: Do people typically get refills for Ice man?

Since the active ingredient is generally used in products that are designated as over-the-counter (OTC) preparations, a typical medical prescription or associated refill is not usually required for continued purchase.


Q: Are there different brand names for the same active ingredient in Ice man?

Yes, Levomenthol is the standard active ingredient found in a large number of different brand-name products internationally. The various brands often use the same ingredient for the relief of minor aches or nasal congestion.


Q: What is a 'contraindication' for Ice man?

A contraindication is a term used in regulatory documents to describe a specific situation in which a medicine should not be used. Official labeling lists certain age groups, conditions like broken skin, and known hypersensitivities as contraindications because its use in that situation may be associated with risk.


Q: What is a 'pharmacological class' for Ice man?

The pharmacological class is a grouping of medicines that share similar characteristics, such as how they work in the body or the condition they are used to treat. Ice man is classified as a topical analgesic and counterirritant because its action is localized and provides symptom relief through a sensory effect.


Q: How quickly can I expect Ice man to start working?

Studies and official information indicate that the effect is generally rapid due to the direct action on sensory nerves. Research suggests that for topical preparations, patients may notice the characteristic cooling sensation quickly, often within a short period following application.


Q: What is the longest time people typically take Ice man for?

Official information describes the product as being intended for short-term, symptomatic use. It is generally applied during acute episodes of discomfort or congestion, such as those associated with the common cold. Regulatory documents do not define a specific maximum duration of application for patients.

How should Ice man be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling dictates specific conditions for storing the Levomenthol preparation, Ice man, to ensure its stability and safety. The product must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F).

Mandatory protection requirements state that the product must be stored away from freezing, excessive heat, direct sunlight, and excessive moisture. Handling instructions specify that the product is flammable and must be kept away from open flame. The product must be kept out of the sight and reach of children at all times.

Disposal of unused or expired quantities of the preparation must be performed according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ice man found in:

A-Z Index: